Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 1906 AL 1920

Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease

Nagori K, Pradhan M, Sharma M, Ajazuddin, Badwaik HR, Nakhate KT.

Curr Alzheimer Res. 2024;21(1):50-68. doi: 10.2174/0115672050306008240321034006.

Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies

Das V, Miller JH, Alladi CG, Annadurai N, De Sanctis JB, Hrubá L, Hajdúch M.

Med Res Rev. 2024 Sep;44(5):2078-2111. doi: 10.1002/med.22033. Epub 2024 Mar 26.

Methylene blue and its potential in the treatment of traumatic brain injury, brain ischemia, and Alzheimer's disease

Isaev NK, Genrikhs EE, Stelmashook EV.

Rev Neurosci. 2024 Mar 27;35(5):585-595. doi: 10.1515/revneuro-2024-0007. Print 2024 Jul 26.

Gene networks and systems biology in Alzheimer's disease: Insights from multi-omics approaches

Rahimzadeh N, Srinivasan SS, Zhang J, Swarup V.

Alzheimers Dement. 2024 May;20(5):3587-3605. doi: 10.1002/alz.13790. Epub 2024 Mar 27.

Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease

Niu C, Dong M, Niu Y.

Eur J Med Chem. 2024 Apr 5;269:116359. doi: 10.1016/j.ejmech.2024.116359. Epub 2024 Mar 25.

Fasting, a Potential Intervention in Alzheimer's Disease

Zeng Z, Zhang H, Wang X, Shen J, Chen D.

J Integr Neurosci. 2024 Mar 4;23(3):50. doi: 10.31083/j.jin2303050.

Microglial Transforming Growth Factor-β Signaling in Alzheimer's Disease

Vidovic N, Spittau B.

Int J Mol Sci. 2024 Mar 7;25(6):3090. doi: 10.3390/ijms25063090.

Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease

Batko J, Antosz K, Miśków W, Pszczołowska M, Walczak K, Leszek J.

Int J Mol Sci. 2024 Mar 17;25(6):3401. doi: 10.3390/ijms25063401.

Alzheimer's Disease: A Molecular Model and Implied Path to Improved Therapy

Weaver-Rosen MS, Serwer P.

Int J Mol Sci. 2024 Mar 20;25(6):3479. doi: 10.3390/ijms25063479.

Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis

Petersen SI, Okolicsanyi RK, Haupt LM.

Cell Mol Neurobiol. 2024 Mar 28;44(1):30. doi: 10.1007/s10571-024-01463-8.

Progressive QTc prolongation and reduced heart rate variability in dementia with Lewy bodies compared to Alzheimer's disease

Haglund M, Heyman I, Javanshiri K.

Parkinsonism Relat Disord. 2024 May;122:106947. doi: 10.1016/j.parkreldis.2024.106947. Epub 2024 Mar 25.

Systematic review and meta-analysis of randomized controlled trials on the effects of exercise interventions on amyloid beta levels in humans

Pucci IM, Aguiar AF, Pucci RM, Casonatto J, Borghi SM.

Exp Brain Res. 2024 May;242(5):1011-1024. doi: 10.1007/s00221-024-06821-y. Epub 2024 Mar 29.

Land/Water Aerobic Activities: Two Sides of the Same Coin. A Comparative Analysis on the Effects in Cognition of Alzheimer's Disease

Gelfo F, Petrosini L, Mandolesi L, Landolfo E, Caruso G, Balsamo F, Bonarota S, Bozzali M, Caltagirone C, Serra L.

J Alzheimers Dis. 2024;98(4):1181-1197. doi: 10.3233/JAD-231279.

The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes

Buchholz S, Zempel H.

Alzheimers Dement. 2024 May;20(5):3606-3628. doi: 10.1002/alz.13784. Epub 2024 Mar 31.

The ABC's of Alzheimer risk gene ABCA7

Duchateau L, Wawrzyniak N, Sleegers K.

Alzheimers Dement. 2024 May;20(5):3629-3648. doi: 10.1002/alz.13805. Epub 2024 Mar 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias